LTR Pharma Limited (AU:LTP) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
LTR Pharma Limited is set to capture attention in the financial markets with its new fast-acting nasal spray treatment for erectile dysfunction, targeting sophisticated investors across multiple countries. The company is actively engaging with institutional accredited investors for capital raising opportunities.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.